239 related articles for article (PubMed ID: 31126146)
41. Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?
Mankaï A; Eveillard JR; Buhé V; Le Ster K; Loisel S; Ghedira I; Youinou P; Berthou C; Bordron A
Ann N Y Acad Sci; 2007 Jun; 1107():193-205. PubMed ID: 17804547
[TBL] [Abstract][Full Text] [Related]
42. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
43. The E3 ubiquitin ligase c-Cbl mediates integrin β1 ubiquitination during dilated cardiomyopathy.
Yang N; Yu F; Shao G; Fu Y; Kong W
Biochem Biophys Res Commun; 2016 Oct; 479(4):728-735. PubMed ID: 27693578
[TBL] [Abstract][Full Text] [Related]
44. Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment.
Liyasova MS; Ma K; Lipkowitz S
Clin Cancer Res; 2015 Apr; 21(8):1789-94. PubMed ID: 25477533
[TBL] [Abstract][Full Text] [Related]
45. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
46. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.
Wang M; Chen B; Ru Z; Cong L
Biochem Biophys Res Commun; 2018 Sep; 504(1):283-288. PubMed ID: 30190130
[TBL] [Abstract][Full Text] [Related]
47. E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation.
Yang WX; Jin R; Jiang CM; Wang XH; Shu J; Li L; Zhu LH; Zhuang LL; Gao C; Zhou GP
FEBS Lett; 2015 Jul; 589(15):1975-80. PubMed ID: 26112603
[TBL] [Abstract][Full Text] [Related]
48. [Implication of the ubiquitin ligase c-Cbl in bone formation and tumorigenesis].
Sévère N; Marie P
Med Sci (Paris); 2012 Nov; 28(11):970-5. PubMed ID: 23171901
[TBL] [Abstract][Full Text] [Related]
49. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
50. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.
Naramura M; Nadeau S; Mohapatra B; Ahmad G; Mukhopadhyay C; Sattler M; Raja SM; Natarajan A; Band V; Band H
Oncotarget; 2011 Mar; 2(3):245-50. PubMed ID: 21422499
[TBL] [Abstract][Full Text] [Related]
51. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
52. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
Mukhopadhyay C; Triplett A; Bargar T; Heckman C; Wagner KU; Naramura M
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8228-E8237. PubMed ID: 27930322
[TBL] [Abstract][Full Text] [Related]
53. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
54. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.
Li Z; Dong T; Pröschel C; Noble M
PLoS Biol; 2007 Feb; 5(2):e35. PubMed ID: 17298174
[TBL] [Abstract][Full Text] [Related]
55. IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases.
Schmid FM; Schou KB; Vilhelm MJ; Holm MS; Breslin L; Farinelli P; Larsen LA; Andersen JS; Pedersen LB; Christensen ST
J Cell Biol; 2018 Jan; 217(1):151-161. PubMed ID: 29237719
[TBL] [Abstract][Full Text] [Related]
56. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
[TBL] [Abstract][Full Text] [Related]
57. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
Nihal M; Wood GS
Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
[TBL] [Abstract][Full Text] [Related]
58. Mutations of c-Cbl in myeloid malignancies.
Katzav S; Schmitz ML
Oncotarget; 2015 May; 6(13):10689-96. PubMed ID: 26028666
[TBL] [Abstract][Full Text] [Related]
59. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
[TBL] [Abstract][Full Text] [Related]
60. Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination.
Lock P; I ST; Straffon AF; Schieb H; Hovens CM; Stylli SS
Biochem Biophys Res Commun; 2006 Dec; 351(4):1018-23. PubMed ID: 17094949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
